Rite Aid Corporation RAD shares have sold off heavily since May 10. Shares have fallen roughly 4.5 percent to $7.73 as of Thursday's close.
The selloff has Credit Suisse analyst Robert Willoughby monitoring the stickiness of the company's valuation in lieu of regulatory hurdles surrounding the merger with Walgreens Boots Alliance WBA.
Willoughby is cutting his FY 2017 EPS estimate for Rite Aid from $0.27 to $0.24, citing declining run rates. He still expects the deal to be blessed by the FCC and is keeping his $9 price target and Outperform rating.
Shares of Rite Aid closed Thursday session down 1.78 percent to $7.72.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.